126 related articles for article (PubMed ID: 1330935)
1. Transforming growth factor beta 1 (TGF-beta 1) inhibits growth of a human ovarian carcinoma cell line (OVCCR1) and is expressed in human ovarian tumors.
Jozan S; Guerrin M; Mazars P; Dutaur M; Monsarrat B; Cheutin F; Bugat R; Martel P; Valette A
Int J Cancer; 1992 Nov; 52(5):766-70. PubMed ID: 1330935
[TBL] [Abstract][Full Text] [Related]
2. Growth regulation of ovarian cancer cells by epidermal growth factor and transforming growth factors alpha and beta 1.
Zhou L; Leung BS
Biochim Biophys Acta; 1992 Dec; 1180(2):130-6. PubMed ID: 1463764
[TBL] [Abstract][Full Text] [Related]
3. Effect of epidermal growth factor/transforming growth factor alpha and transforming growth factor beta 1 on growth in vitro of rat urinary bladder carcinoma cells.
Kawamata H; Azuma M; Kameyama S; Nan L; Oyasu R
Cell Growth Differ; 1992 Nov; 3(11):819-25. PubMed ID: 1467309
[TBL] [Abstract][Full Text] [Related]
4. Resistance to growth inhibition by transforming growth factor-beta in malignant glioma cells with functional receptors.
Isoe S; Naganuma H; Nakano S; Sasaki A; Satoh E; Nagasaka M; Maeda S; Nukui H
J Neurosurg; 1998 Mar; 88(3):529-34. PubMed ID: 9488308
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta mRNA expression and growth control of human ovarian carcinoma cells.
Bartlett JM; Rabiasz GJ; Scott WN; Langdon SP; Smyth JF; Miller WR
Br J Cancer; 1992 May; 65(5):655-60. PubMed ID: 1586592
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibition of transforming growth factor beta on human gastric carcinoma cells: receptor and postreceptor signaling.
Ito M; Yasui W; Kyo E; Yokozaki H; Nakayama H; Ito H; Tahara E
Cancer Res; 1992 Jan; 52(2):295-300. PubMed ID: 1309437
[TBL] [Abstract][Full Text] [Related]
7. Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors.
MacKay SL; Yaswen LR; Tarnuzzer RW; Moldawer LL; Bland KI; Copeland EM; Schultz GS
Ann Surg; 1995 Jun; 221(6):767-76; discussion 776-7. PubMed ID: 7794080
[TBL] [Abstract][Full Text] [Related]
8. Effect of epidermal growth factor and transforming growth factor beta 1 on growth and invasive potentials of newly established rat bladder carcinoma cell lines.
Kawamata H; Kameyama S; Nan L; Kawai K; Oyasu R
Int J Cancer; 1993 Dec; 55(6):968-73. PubMed ID: 8253534
[TBL] [Abstract][Full Text] [Related]
9. Autocrine growth mechanism by transforming growth factor (TGF)-beta 1 and TGF-beta 1-receptor regulation by epidermal growth factor in a human endometrial cancer cell line IK-90.
Sakata M; Kurachi H; Ikegami H; Jikihara H; Morishige K; Miyake A; Terakawa N; Tanizawa O
Int J Cancer; 1993 Jul; 54(5):862-7. PubMed ID: 8392035
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta 1 supports autonomous growth of human papillomavirus-immortalized cervical keratinocytes under conditions promoting squamous differentiation.
Woodworth CD; Chung J; McMullin E; Plowman GD; Simpson S; Iglesias M
Cell Growth Differ; 1996 Jun; 7(6):811-20. PubMed ID: 8780894
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells.
Elbendary A; Berchuck A; Davis P; Havrilesky L; Bast RC; Iglehart JD; Marks JR
Cell Growth Differ; 1994 Dec; 5(12):1301-7. PubMed ID: 7696178
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW
Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633
[TBL] [Abstract][Full Text] [Related]
13. Desensitization of melanoma cells to autocrine TGF-beta isoforms.
Krasagakis K; Krüger-Krasagakes S; Fimmel S; Eberle J; Thölke D; von der Ohe M; Mansmann U; Orfanos CE
J Cell Physiol; 1999 Feb; 178(2):179-87. PubMed ID: 10048582
[TBL] [Abstract][Full Text] [Related]
14. Anomalies of the TGF-beta postreceptor signaling pathway in ovarian cancer cell lines.
Hu W; Wu W; Nash MA; Freedman RS; Kavanagh JJ; Verschraegen CF
Anticancer Res; 2000; 20(2A):729-33. PubMed ID: 10810347
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-alpha acts as an autocrine growth factor in ovarian carcinoma cell lines.
Stromberg K; Collins TJ; Gordon AW; Jackson CL; Johnson GR
Cancer Res; 1992 Jan; 52(2):341-7. PubMed ID: 1309440
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta (TGF beta) inhibits TGF alpha expression in bovine anterior pituitary-derived cells.
Mueller SG; Kudlow JE
Mol Endocrinol; 1991 Oct; 5(10):1439-46. PubMed ID: 1723143
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the involvement of transforming growth factor alpha and epidermal growth factor receptor autocrine growth mechanism in primary human ovarian cancers in vitro.
Morishige K; Kurachi H; Amemiya K; Fujita Y; Yamamoto T; Miyake A; Tanizawa O
Cancer Res; 1991 Oct; 51(19):5322-8. PubMed ID: 1717146
[TBL] [Abstract][Full Text] [Related]
18. Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling.
Baldwin RL; Tran H; Karlan BY
Cancer Res; 2003 Mar; 63(6):1413-9. PubMed ID: 12649207
[TBL] [Abstract][Full Text] [Related]
19. Progressive abrogation of TGF-beta 1 and EGF growth control is associated with tumour progression in ras-transfected human keratinocytes.
Game SM; Huelsen A; Patel V; Donnelly M; Yeudall WA; Stone A; Fusenig NE; Prime SS
Int J Cancer; 1992 Sep; 52(3):461-70. PubMed ID: 1328069
[TBL] [Abstract][Full Text] [Related]
20. Involvement of transforming growth factor alpha/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vitro.
Morishige K; Kurachi H; Amemiya K; Adachi H; Inoue M; Miyake A; Tanizawa O; Sakoyama Y
Cancer Res; 1991 Nov; 51(21):5951-5. PubMed ID: 1718591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
